Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
D000328:Adult; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002251:Carbon Tetrachloride / Q000627:therapeutic use; D002738:Chloroquine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D003676:Deferoxamine; D006801:Humans; D007501:Iron / Q000378:metabolism / Q000652:urine; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism / Q000652:urine; D011166:Porphyrins / Q000652:urine; D051381:Rats; D012008:Recurrence
D011166:Porphyrins; D002738:Chloroquine; D002251:Carbon Tetrachloride; D007501:Iron; D001219:Aspartate Aminotransferases; D003676:Deferoxamine